Dn B Asset Management As Dexcom Inc Transaction History

Dn B Asset Management As

$21.2 Billion
Q1 2025

A detailed history of Dn B Asset Management As transactions in Dexcom Inc stock. As of the latest transaction made, Dn B Asset Management As holds 289,711 shares of DXCM stock, worth $24.8 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

289,711

Previous 246,385 17.58%

Holding current value

$24.8 Million

Previous $19.2 Million 3.25%

% of portfolio

0.09%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$67.74 - $90.75 $2.93 Million - $3.93 Million	43,326 Added 17.58%	289,711 $19.8 Million
Q4 2024 Feb 12, 2025	BUY	$65.68 - $81.01 $1.57 Million - $1.94 Million	23,914 Added 10.75%	246,385 $19.2 Million
Q3 2024 Nov 12, 2024	BUY	$64.0 - $116.06 $5.01 Million - $9.09 Million	78,279 Added 54.29%	222,471 $14.9 Million
Q2 2024 Jul 05, 2024	BUY	$110.31 - $140.45 $4.94 Million - $6.29 Million	44,752 Added 45.0%	144,192 $16.3 Million
Q1 2024 Apr 12, 2024	SELL	$114.22 - $140.1 $1.17 Million - $1.43 Million	-10,221 Reduced 9.32%	99,440 $13.8 Million
Q4 2023 Jan 04, 2024	SELL	$75.49 - $124.16 $35,253 - $57,982	-467 Reduced 0.42%	109,661 $13.6 Million
Q3 2023 Oct 13, 2023	BUY	$86.06 - $137.93 $3.47 Million - $5.56 Million	40,333 Added 57.79%	110,128 $10.3 Million
Q2 2023 Jul 06, 2023	SELL	$112.47 - $130.98 $33,516 - $39,032	-298 Reduced 0.43%	69,795 $8.97 Million
Q1 2023 Apr 20, 2023	BUY	$104.0 - $122.92 $360,256 - $425,794	3,464 Added 5.2%	70,093 $8.14 Million
Q4 2022 Jan 12, 2023	BUY	$84.98 - $122.67 $225,281 - $325,198	2,651 Added 4.14%	66,629 $7.55 Billion
Q3 2022 Oct 11, 2022	SELL	$76.35 - $94.18 $57,567 - $71,011	-754 Reduced 1.16%	63,978 $5.15 Million
Q2 2022 Jul 08, 2022	BUY	$67.99 - $132.89 $3.34 Million - $6.53 Million	49,171 Added 315.99%	64,732 $4.82 Billion
Q1 2022 Apr 08, 2022	BUY	$94.08 - $130.2 $88,058 - $121,867	936 Added 6.4%	15,561 $1.99 Million
Q4 2021 Jan 12, 2022	BUY	$129.87 - $162.82 $73,116 - $91,667	563 Added 4.0%	14,625 $1.96 Million
Q3 2021 Oct 15, 2021	BUY	$106.71 - $143.18 $42,363 - $56,842	397 Added 2.91%	14,062 $1.92 Million
Q2 2021 Jul 06, 2021	SELL	$80.99 - $107.93 $215,838 - $287,633	-2,665 Reduced 16.32%	13,665 $5.83 Billion
Q1 2021 Apr 15, 2021	BUY	$84.79 - $104.74 $401,565 - $496,048	4,736 Added 40.85%	16,330 $1.47 Million
Q4 2020 Jan 19, 2021	BUY	$78.0 - $104.5 $63,414 - $84,958	813 Added 7.54%	11,594 $1.07 Million
Q3 2020 Oct 14, 2020	BUY	$95.51 - $112.95 $69,626 - $82,340	729 Added 7.25%	10,781 $1.11 Million
Q2 2020 Jul 08, 2020	BUY	$62.68 - $105.34 $630,059 - $1.06 Million	10,052 New	10,052 $4.08 Billion
Q1 2020 Apr 17, 2020	SELL	$47.79 - $75.63 $486,836 - $770,442	-10,187 Closed	0 $0
Q4 2019 Jan 13, 2020	BUY	$36.62 - $57.29 $373,047 - $583,613	10,187 New	10,187 $557,000

Others Institutions Holding DXCM

# of Institutions

1,083

Shares Held

362M

Call Options Held

5.4M

Put Options Held

4.3M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.

Account

Dn B Asset Management As Dexcom Inc Transaction History